Skip to main content
Figure 1 | Cancer Cell International

Figure 1

From: Inhibition of androgen-independent prostate cancer cell growth is enhanced by combination therapy targeting Hedgehog and ErbB signalling

Figure 1

Circulating tumour cells isolated from AIPC patients are EpCAM, PTCH, ErbB2 and EGFR positive. (A) EpCAM, PTCH, ErbB2 and EGFR immunofluorescence in circulating tumour cells isolated from AIPC patients. (B) Relative PTCH, EGFR, ErbB2 and DD3PCA3 RNA expression in circulating tumour cells isolated from normal subjects and androgen-independent prostate cancer patients.

Back to article page

Cancer Cell International

ISSN: 1475-2867

Contact us